Dengue virus genome uncoating requires ubiquitination

mBio

Volumn 7, Issue 3, 2016, Pages

  Byk, Laura A ^a   Iglesias, Néstor G ^a   De Maio, Federico A ^a   Gebhard, Leopoldo G ^a   Rossi, Mario ^b   Gamarnik, Andrea V ^a  

^a FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^b Polo Científico Tecnológico ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; GENOMIC RNA; PROTEASOME; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; VIRUS RNA;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; ENDOSOME; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; UBIQUITINATION; VIRUS CAPSID; VIRUS ENTRY; VIRUS GENOME; VIRUS NUCLEOCAPSID; VIRUS RELEASE; VIRUS TRANSCRIPTION; VIRUS UNCOATING; A-549 CELL LINE; ANIMAL; CELL LINE; GENETICS; HAMSTER; METABOLISM; MUTATION; PHYSIOLOGY; VIRION;

A549 CELLS; ANIMALS; CAPSID; CAPSID PROTEINS; CELL LINE; CRICETINAE; DENGUE; DENGUE VIRUS; GENOME, VIRAL; HUMANS; MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, VIRAL; UBIQUITINATION; VIRION; VIRUS INTERNALIZATION; VIRUS RELEASE; VIRUS UNCOATING;

EID: 84978985593     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00804-16     Document Type: Article

References (34)

1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI. 2013. The global distribution and burden of dengue. Nature 496: 504-507. http://dx.doi.org/10.1038/nature12060.
2. Rice CM, Lenches EM, Eddy SR, Shin SJ, Sheets RL, Strauss JH. 1985. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229: 726-733. http://dx.doi.org/10.1126/science.4023707.
3. Iglesias NG, Byk LA, Gamarnik AV. 2014. Molecular virology of dengue virus, p 334-364. In Gubler DJ, Ooi EE, Vasudevan S, Farrar J (ed), Dengue and dengue hemorrhagic fever, 2nd ed. CABI, Egham, United Kingdom.
4. Ma L, Jones CT, Groesch TD, Kuhn RJ, Post CB. 2004. Solution structure of dengue virus capsid protein reveals another fold. Proc Natl Acad Sci U S A 101: 3414-3419. http://dx.doi.org/10.1073/ pnas.0305892101.
5. Samsa MM, Mondotte JA, Caramelo JJ, Gamarnik AV. 2012. Uncoupling cis-acting RNA elements from coding sequences revealed a requirement of the N-terminal region of dengue virus capsid protein in virus particle formation. J Virol 86: 1046-1058. http://dx.doi.org/10.1128/ JVI.05431-11.
6. Khromykh AA, Westaway EG. 1996. RNA binding properties of core protein of the flavivirus Kunjin. Arch Virol 141: 685-699. http:// dx.doi.org/10.1007/BF01718326.
7. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss EG, Baker TS, Strauss JH. 2002. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108: 717-725. http:// dx.doi.org/10.1016/S0092-8674(02)00660-8.
8. Zhang W, Chipman PR, Corver J, Johnson PR, Zhang Y, Mukhopad-hyay S, Baker TS, Strauss JH, Rossmann MG, Kuhn RJ. 2003. Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol 10: 907-912. http://dx.doi.org/10.1038/ nsb990.
9. Byrd CM, Dai D, Grosenbach DW, Berhanu A, Jones KF, Cardwell KB, Schneider C, Wineinger KA, Page JM, Harver C, Stavale E, Tyavanagimatt S, Stone MA, Bartenschlager R, Scaturro P, Hruby DE, Jordan R. 2013. A novel inhibitor of dengue virus replication that targets the capsid protein. Antimicrob Agents Chemother 57: 15-25. http://dx.doi.org/10.1128/AAC.01429-12.
10. Scaturro P, Trist IM, Paul D, Kumar A, Acosta EG, Byrd CM, Jordan R, Brancale A, Bartenschlager R. 2014. Characterization of the mode of action of a potent dengue virus capsid inhibitor. J Virol 88: 11540-11555. http://dx.doi.org/10.1128/JVI.01745-14.
11. Mateo R, Nagamine CM, Kirkegaard K. 2015. Suppression of drug resistance in dengue virus. mBio 6: e01960-15. http://dx.doi.org/10.1128/ mBio.01960-15.
12. Sangiambut S, Keelapang P, Aaskov J, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N. 2008. Multiple regions in dengue virus capsid protein contribute to nuclear localization during virus infection. J Gen Virol 89: 1254-1264. http://dx.doi.org/10.1099/vir.0.83264-0.
13. Wang SH, Syu WJ, Huang KJ, Lei HY, Yao CW, King CC, Hu ST. 2002. Intracellular localization and determination of a nuclear localization signal of the core protein of dengue virus. J Gen Virol 83: 3093-3102. http:// dx.doi.org/10.1099/0022-1317-83-12-3093.
14. Samsa MM, Mondotte JA, Iglesias NG, Assunção-Miranda I, Barbosa-Lima G, Da Poian AT, Bozza PT, Gamarnik AV. 2009. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog 5: e1000632. http://dx.doi.org/10.1371/journal.ppat.1000632.
15. Tadano M, Makino Y, Fukunaga T, Okuno Y, Fukai K. 1989. Detection of dengue 4 virus core protein in the nucleus. I. A monoclonal antibody to dengue 4 virus reacts with the antigen in the nucleus and cytoplasm. J Gen Virol 70 (Pt 6): 1409-1415. http://dx.doi.org/10.1099/0022-1317-70-6-1409.
16. Bulich R, Aaskov JG. 1992. Nuclear localization of dengue 2 virus core protein detected with monoclonal antibodies. J Gen Virol 73 (Pt 11): 2999-3003. http://dx.doi.org/10.1099/0022-1317-73-11-2999.
17. Iglesias NG, Mondotte JA, Byk LA, De Maio FA, Samsa MM, Alvarez C, Gamarnik AV. 2015. Dengue virus uses a non-canonical function of the host GBF1-Arf-COPI system for capsid protein accumulation on lipid droplets. Traffic 16: 962-977. http://dx.doi.org/10.1111/tra.12305.
18. Modis Y, Ogata S, Clements D, Harrison SC. 2004. Structure of the dengue virus envelope protein after membrane fusion. Nature 427: 313-319. http://dx.doi.org/10.1038/nature02165.
19. Nayak V, Dessau M, Kucera K, Anthony K, Ledizet M, Modis Y. 2009. Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J Virol 83: 4338-4344. http://dx.doi.org/10.1128/JVI.02574-08.
20. Mercer J, Snijder B, Sacher R, Burkard C, Bleck CK, Stahlberg H, Pelkmans L, Helenius A. 2012. RNAi screening reveals proteasome-and Cullin3-dependent stages in vaccinia virus infection. Cell Rep 2: 1036-1047. http://dx.doi.org/10.1016/j.celrep.2012.09.003.
21. Singh I, Helenius A. 1992. Role of ribosomes in Semliki Forest virus nucleocapsid uncoating. J Virol 66: 7049-7058.
22. Piper RC, Dikic I, Lukacs GL. 1 January 2014. Ubiquitin-dependent sorting in endocytosis. Cold Spring Harb Perspect Biol 6. http:// dx.doi.org/10.1101/cshperspect.a016808.
23. Greene W, Zhang W, He M, Witt C, Ye F, Gao SJ. 2012. The ubiquitin/ proteasome system mediates entry and endosomal trafficking of Kaposi’s sarcoma-associated herpesvirus in endothelial cells. PLoS Pathog 8: e1002703. http://dx.doi.org/10.1371/journal.ppat.1002703.
24. Su WC, Chen YC, Tseng CH, Hsu PW, Tung KF, Jeng KS, Lai MM. 2013. Pooled RNAi screen identifies ubiquitin ligase Itch as crucial for influenza A virus release from the endosome during virus entry. Proc Natl Acad Sci U S A 110: 17516-17521. http://dx.doi.org/10.1073/ pnas.1312374110.
25. Huotari J, Meyer-Schaller N, Hubner M, Stauffer S, Katheder N, Horvath P, Mancini R, Helenius A, PeterM. 2012. Cullin-3 regulates late endosome maturation. Proc Natl Acad Sci U S A 109: 823-828. http:// dx.doi.org/10.1073/pnas.1118744109.
26. Enchev RI, Schulman BA, Peter M. 2015. Protein neddylation: beyond cullin-RING ligases. Nat Rev Mol Cell Biol 16: 30-44. http://dx.doi.org/10.1038/nrm3919.
27. Zhou HL, Geng C, Luo G, Lou H. 2013. The p97-UBXD8 complex destabilizes mRNA by promoting release of ubiquitinated HuR from mRNP. Genes Dev 27: 1046-1058. http://dx.doi.org/10.1101/ gad.215681.113.
28. Banerjee I, Miyake Y, Nobs SP, Schneider C, Horvath P, Kopf M, Matthias P, Helenius A, Yamauchi Y. 2014. Influenza A virus uses the aggresome processing machinery for host cell entry. Science 346: 473-477. http://dx.doi.org/10.1126/science.1257037.
29. Kanlaya R, Pattanakitsakul SN, Sinchaikul S, Chen ST, Thongboonkerd V. 2010. The ubiquitin-proteasome pathway is important for dengue virus infection in primary human endothelial cells. J Proteome Res 9: 4960-4971. http://dx.doi.org/10.1021/pr100219y.
30. Krishnan MN, Ng A, Sukumaran B, Gilfoy FD, Uchil PD, Sultana H, Brass AL, Adametz R, Tsui M, Qian F, Montgomery RR, Lev S, Mason PW, Koski RA, Elledge SJ, Xavier RJ, Agaisse H, Fikrig E. 2008. RNA interference screen for human genes associated with West Nile virus infection. Nature 455: 242-245. http://dx.doi.org/10.1038/nature07207.
31. Fernandez-Garcia MD, Meertens L, Bonazzi M, Cossart P, Arenzana-Seisdedos F, Amara A. 2011. Appraising the roles of CBLL1 and the ubiquitin/proteasome system for flavivirus entry and replication. J Virol 85: 2980-2989. http://dx.doi.org/10.1128/JVI.02483-10.
32. Klumpp K, Crépin T. 2014. Capsid proteins of enveloped viruses as antiviral drug targets. Curr Opin Virol 5: 63-71. http://dx.doi.org/10.1016/j.coviro.2014.02.002.
33. Kinney RM, Butrapet S, Chang GJ, Tsuchiya KR, Roehrig JT, Bhamarapravati N, Gubler DJ. 1997. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 230: 300-308. http://dx.doi.org/10.1006/ viro.1997.8500.
34. Oliphant T, Engle M, Nybakken GE, Doane C, Johnson S, Huang L, Gorlatov S, Mehlhop E, Marri A, Chung KM, Ebel GD, Kramer LD, Fremont DH, Diamond MS. 2005. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med 11: 522-530. http://dx.doi.org/10.1038/nm1240.